Author

Geng-Hong Di

Observed names: DI Geng-hong, Gen-Hong DI, Gen-hong DI, Geng Hong Di, Geng-hong DI

Observed institutions: Shanghai Medical College of Fudan University, Fudan University, Fudan University Shanghai Cancer Center

OpenAlex ID: A5115588461

Higher rate of skin rash in a phase II trial with weekly nanoparticle albumin-bound paclitaxel and cisplatin combination in Chinese breast cancer patients

2013 · Li Chen Tang, Bi Yun Wang, et al. · BMC Cancer · 15

Test of Hardy–Weinberg equilibrium in breast cancer case-control studies: an issue may influence the conclusions

2009 · Ke-Da Yu, Geng-Hong Di, et al. · Breast Cancer Research and Treatment · 13

Risk factors for postoperative seromas in Chinese breast cancer patients.

2011 · Yan-ping Lin, Wen-jin Yin, et al. · PubMed · 8

[BRCA1/2 gene mutation in Chinese familial breast cancer patients: a multi-center report of 115 cases].

2008 · Zhen Hu, Wen-Feng Li, et al. · PubMed · 4

[Retrospective analysis of trastuzumab treatment in 141 patients with Her-2 positive breast cancer].

2010 · Yan Wang, Jun-jie Li, et al. · PubMed · 1

Abstract GS1-04: HER2-Directed Antibody-Drug Conjugate SHR-A1811 in the Neoadjuvant Treatment of HER2-positive Early Breast Cancer: a Prospective, Randomized, Open-label, Phase 2 Trial

2025 · Junjie Li, Zhong-Hua Wang, et al. · Clinical Cancer Research

Detection of minimal residual disease and immunologic microenvironment in bone marrow of breast cancer patients

2006 · DI Geng-hong · Zhonghua shiyan waike zazhi

Works count: 7

Citation count: 41

H-index: 4

I10-index: 2